Non Small Cell Lung Cancer

SEP 9, 2026 · OBSERVATIONAL STUDY

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

ClinicalTrials.gov

This is a registry record for an active observational study with no results posted; it describes planned enrollment and methods only, without outcome data.

SEP 9, 2026 · PHASE 3 TRIAL

A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is an active clinical trial registry record with no posted results; the study design and planned endpoints are documented but outcome data are not yet reported.

SEP 9, 2026 · PHASE 2 TRIAL

Study of TUB-040 in Participants With Unresectable or Metastatic Nonsquamous Non-small Cell Lung Cancer

ClinicalTrials.gov

This is a planned Phase 2 interventional trial with no results posted; it is in pre-recruitment stage and represents early-phase development of TUB-040 in NSCLC.

SEP 8, 2026 · PHASE 1/2 TRIAL

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 1/2 trial registration with recruitment suspended; no results are posted, making it an early-stage study design record without outcome data.

SEP 8, 2026 · PHASE 1 TRIAL

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

ClinicalTrials.gov

This is a first-in-human Phase 1 trial registration with no results posted; the study is not yet recruiting and therefore represents early-stage, pre-clinical development work.

SEP 8, 2026 · PHASE 3 TRIAL

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is actively recruiting and has not yet reported efficacy or safety outcomes.

SEP 8, 2026 · PHASE 3 TRIAL

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a clinical trial registry record describing a Phase 3 study that is currently recruiting with no results posted; it documents planned design and endpoints only.

SEP 8, 2026 · PHASE 2 TRIAL

RADICAL-IO: thRee Cycles of immunotherApy Without raDical Therapy In mediCALly InOperable Stage I Non-small Cell Lung Cancer

ClinicalTrials.gov

This is an unstarted Phase 2 interventional trial with no posted results; it is a study design and rationale only, representing early-stage exploration of immunotherapy monotherapy in a selected population.